• CVS Health plans to split into two publicly traded companies, separating retail pharmacy from healthcare solutions in the first half of 2028.
• The November 4, 2026, third-quarter earnings call featured CEO J. David Joyner, CFO Brian O. Newman and other executives.
• The healthcare solutions business will retain Aetna, Caremark and specialty pharmacy; CVS Pharmacy will include retail stores, mail order and community healthcare.
• Management raised 2026 adjusted EPS guidance to at least $8.20 from $7.90-$8.10; operating cash flow is forecast at least $15.5 billion.
• The 2027 adjusted EPS outlook is at least $8.65; share repurchases will resume in the fourth quarter of 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CVS Health Corporation published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.